| Primary |
| Hypersensitivity |
33.8% |
| Rhinorrhoea |
12.6% |
| Sneezing |
10.8% |
| Seasonal Allergy |
6.8% |
| Eye Pruritus |
6.1% |
| Lacrimation Increased |
4.4% |
| Nasal Congestion |
3.8% |
| Throat Irritation |
3.6% |
| Hypertension |
2.8% |
| Nasal Discomfort |
2.5% |
| Headache |
1.9% |
| Nasopharyngitis |
1.6% |
| Cough |
1.4% |
| Oropharyngeal Pain |
1.3% |
| Sinus Disorder |
1.3% |
| Asthenia |
1.1% |
| Diabetes Mellitus |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Pruritus |
1.1% |
| Routine Health Maintenance |
1.1% |
|
| Drug Ineffective |
44.5% |
| Drug Effect Decreased |
12.9% |
| Overdose |
4.9% |
| Somnolence |
4.6% |
| Insomnia |
4.0% |
| Nausea |
3.1% |
| Urticaria |
3.1% |
| Blood Pressure Increased |
2.5% |
| Dizziness |
2.1% |
| Feeling Abnormal |
2.1% |
| Nasal Congestion |
2.1% |
| Epistaxis |
1.8% |
| Pruritus |
1.8% |
| Malaise |
1.5% |
| Nervousness |
1.5% |
| Palpitations |
1.5% |
| Rhinorrhoea |
1.5% |
| Throat Irritation |
1.5% |
| Vomiting |
1.5% |
| Fatigue |
1.2% |
|
| Secondary |
| Rhinorrhoea |
16.6% |
| Sneezing |
16.4% |
| Hypersensitivity |
12.7% |
| Eye Pruritus |
11.9% |
| Lacrimation Increased |
8.9% |
| Throat Irritation |
6.7% |
| Nasal Discomfort |
4.7% |
| Nasal Congestion |
4.2% |
| Hypertension |
2.9% |
| Headache |
2.6% |
| Oropharyngeal Pain |
2.1% |
| Pruritus |
2.0% |
| Cough |
1.8% |
| Seasonal Allergy |
1.8% |
| Ear Pruritus |
0.9% |
| Nasopharyngitis |
0.9% |
| Tympanic Membrane Disorder |
0.8% |
| Drug Use For Unknown Indication |
0.7% |
| Paranasal Sinus Hypersecretion |
0.7% |
| Blood Cholesterol Increased |
0.6% |
|
| Drug Ineffective |
50.6% |
| Drug Effect Decreased |
8.9% |
| Overdose |
7.6% |
| Intentional Overdose |
3.8% |
| Abdominal Discomfort |
3.0% |
| Epistaxis |
3.0% |
| Lacrimation Increased |
2.5% |
| Rhinorrhoea |
2.5% |
| Tremor |
2.5% |
| Agitation |
1.7% |
| Nausea |
1.7% |
| Rash Macular |
1.7% |
| Somnolence |
1.7% |
| Musculoskeletal Pain |
1.3% |
| Product Quality Issue |
1.3% |
| Productive Cough |
1.3% |
| Reflux Gastritis |
1.3% |
| Sluggishness |
1.3% |
| Tablet Physical Issue |
1.3% |
| Thyroid Disorder |
1.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.4% |
| Product Used For Unknown Indication |
14.2% |
| Hypersensitivity |
6.7% |
| Back Pain |
4.6% |
| Osteoporosis |
4.4% |
| Asthma |
4.2% |
| Hypertension |
4.2% |
| Smoking Cessation Therapy |
4.1% |
| Multiple Sclerosis |
3.6% |
| Depression |
3.0% |
| Multiple Allergies |
2.9% |
| Gout |
2.6% |
| Osteoarthritis |
2.5% |
| Diabetes Mellitus |
2.2% |
| Pain |
2.0% |
| Contraception |
1.9% |
| Menopause |
1.9% |
| Multiple Myeloma |
1.9% |
| Premedication |
1.9% |
| Migraine |
1.8% |
|
| Pulmonary Embolism |
10.5% |
| Weight Increased |
8.8% |
| Suicidal Ideation |
7.9% |
| Urinary Tract Infection |
7.9% |
| Syncope |
7.0% |
| Rash |
6.1% |
| Vomiting |
5.3% |
| Weight Decreased |
5.3% |
| Therapeutic Agent Toxicity |
4.4% |
| Tremor |
4.4% |
| Wound Dehiscence |
4.4% |
| Dyspnoea |
3.5% |
| Insomnia |
3.5% |
| Pregnancy |
3.5% |
| Tendon Pain |
3.5% |
| Tooth Fracture |
3.5% |
| Completed Suicide |
2.6% |
| Deep Vein Thrombosis |
2.6% |
| Depression |
2.6% |
| Flatulence |
2.6% |
|
| Interacting |
| Blood Pressure Abnormal |
20.0% |
| Nasopharyngitis |
20.0% |
| Rhinitis Allergic |
20.0% |
| Anxiety |
10.0% |
| Arthritis |
10.0% |
| Bladder Disorder |
10.0% |
| Hormone Replacement Therapy |
10.0% |
|
| Drug Interaction |
50.0% |
| Dizziness |
25.0% |
| Nervousness |
25.0% |
|
